Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00421707 · ClinicalTrials.gov registry record · Phase 2
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
A Phase 2 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 2
- Development phase
- 133
- Enrollment target
NCT00421707 is a Phase 2 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 133 participants.
The verdict
NCT00421707, a Phase 2 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 133 participants
- Enrollment target
Study Summary
This is a double-blind, placebo-controlled, randomised crossover study to investigate the efficacy and safety of GW876008
Interventions
- OTHER Placebo
- DRUG GW876008
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2006-10-14 |
| Est. Completion | 2008-06-25 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00421707
The ClinicalTrials.gov registry entry for NCT00421707 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 133 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00421707 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00421707 about?
NCT00421707 is a clinical study titled "Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome". This is a double-blind, placebo-controlled, randomised crossover study to investigate the efficacy and safety of GW876008
What is the current status of trial NCT00421707?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 133 participants. The study started on 2006-10-14. Estimated completion is 2008-06-25.
What interventions are being tested in trial NCT00421707?
The interventions under investigation include: Placebo (OTHER), GW876008 (DRUG).
Who is sponsoring clinical trial NCT00421707?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.